It also enhanced smooth muscle actin (SMA) and collagen IV (Col IV) coverage of CD31+ tumor vessels (Supplemental Figure 5, D–F), which are features linked to tumor vessel “normalization” (26). The gene discussed is SMN1; the disease is neoplasm.